000 | 01897 a2200553 4500 | ||
---|---|---|---|
005 | 20250513040608.0 | ||
264 | 0 | _c19931209 | |
008 | 199312s 0 0 fre d | ||
022 | _a0761-8425 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKleisbauer, J P | |
245 | 0 | 0 |
_a[Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology]. _h[electronic resource] |
260 |
_bRevue des maladies respiratoires _c1993 |
||
300 |
_a307-12 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study; Review | ||
650 | 0 | 4 | _aActuarial Analysis |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aCarcinoma, Bronchogenic _xdrug therapy |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukopenia _xchemically induced |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMitomycins _xadministration & dosage |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPalliative Care _xmethods |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aVindesine _xadministration & dosage |
650 | 0 | 4 | _aWeight Loss |
700 | 1 | _aThomas, P | |
700 | 1 | _aPerol, M | |
700 | 1 | _aTaytard, A | |
700 | 1 | _aPoirier, R | |
700 | 1 | _aCollus, M J | |
700 | 1 | _aGuerin, J C | |
700 | 1 | _aVergnenegre, A | |
700 | 1 | _aBalmes, P | |
700 | 1 | _aCarles, P | |
773 | 0 |
_tRevue des maladies respiratoires _gvol. 10 _gno. 4 _gp. 307-12 |
|
999 |
_c7693746 _d7693746 |